B. Cho

发表

Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation

S. Lee, S. Lee, A. Kwon, 2015, Bone Marrow Transplantation.

[Usefulness of real-time semi-quantitative PCR, JAK2 MutaScreen kit for JAK2 V617F screening].

Yonggoo Kim, J. Lee, Myungshin Kim, 2009, The Korean journal of laboratory medicine.

Severe renal tubular acidosis in a renal transplant recipient with repeated acute rejections and chronic allograft nephropathy.

Chul-woo Yang, J. Kim, Hyung Wook Kim, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL

S. Lee, Y. Kim, Y. Kim, 2015, Bone Marrow Transplantation.

Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia

J. W. Lee, S. Lee, Y. Kim, 2016, Bone Marrow Transplantation.

PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALL

S. Lee, Y. Kim, H. Kim, 2014, Bone Marrow Transplantation.

Feasibility of NIH consensus criteria for chronic graft-versus-host disease

S. Lee, Y. Kim, H. Kim, 2009, Leukemia.

Azacytidine treatment after discontinuation of immunosuppressants in patients with myelodysplastic syndrome and relapse after allo-SCT at a single center

S. Lee, Y. Kim, H. Kim, 2010, Bone Marrow Transplantation.

Potential role of adoptively transferred allogeneic WT1-specific CD4+ and CD8+ T lymphocytes for the sustained remission of refractory AML

S. Lee, Y. Kim, H. Kim, 2010, Bone Marrow Transplantation.

Influence of killer cell immunoglobulin-like receptor genotypes on acute graft-vs-host disease after unrelated hematopoietic stem cell transplantation in Koreans.

Y. Kim, D-W. Kim, C. Min, 2007, Tissue antigens.

Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

S. Lee, Y. Kim, H. Kim, 2008, Bone Marrow Transplantation.

Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia

S. Lee, Y. Kim, Y. Kim, 2012, Leukemia.

Risk and prognostic factors for acute GVHD based on NIH consensus criteria

Y. Kim, H. Kim, D-W. Kim, 2013, Bone Marrow Transplantation.

Anti-leukaemic role of acute GvHD after unrelated haematopoietic stem cell transplantation in intermediate- to high-risk acute myelogenous leukaemia

S. Lee, H. Kim, D-W. Kim, 2007, Bone Marrow Transplantation.

Overcoming various comorbidities by G-CSF-primed unmanipulated BM SCT in adult patients with AML

S. Lee, Y. Kim, H. Kim, 2009, Bone Marrow Transplantation.

HLA-matched sibling transplantation with BM and CD34+-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD

J. W. Lee, H. Kim, S. Lee, 2010, Bone Marrow Transplantation.

ORIGINAL ARTICLE Feasibility of NIH consensus criteria for chronic graft-versus-host disease

Y. Kim, Sy Lee, H. Kim, 2009 .

Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study

S. Lee, Y. Kim, H. Kim, 2009, Leukemia.

Donor-specific differences in long-term outcomes of myeloablative transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia

S. Lee, Y. Kim, H. Kim, 2010, Leukemia.

Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?

S. Lee, Y. Kim, H. Kim, 2013, Bone Marrow Transplantation.

Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome

Y. Kim, H. Kim, C. Min, 2017, Bone Marrow Transplantation.

Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure

Y. Kim, H. Kim, D-W. Kim, 2013, Bone Marrow Transplantation.

Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation

S. Lee, Y. Kim, H. Kim, 2014, Bone Marrow Transplantation.